OFFICIAL LEGAL TITLE
Facilitating Innovative Nuclear Diagnostics Act of 2021
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 117_S_2609.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2021-08-04.
What are the main provisions?
Key points include:
- Introduction of separate payments for certain diagnostic radiopharmaceuticals under Medicare, instead of packaging their costs.
- Medicare beneficiaries will not see changes in their copayments as a result of these regulations.
- Changes take effect for services furnished on or after January 1, 2022.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Blackburn, Marsha [R-TN].
What is the latest detailed status?
The latest detailed status is: Introduced in Senate
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.